Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. (From -To)
REPORT DATE (DD-MM-YYYY)
01-01-2008
REPORT TYPE
Annual
DATES COVERED
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBERUniversity Of Texas Medical Branch Galveston, Texas, 77555-0143
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACTOur patch clamp studies indicate MscCa is expressed by the invasive prostate tumor cell PC-3. Anti-MscCa agents, Gd3+, GsmTx-4, and an anti-TRPC1 antibody block PC-3 cell migration. MscCa activity can be recorded over the surface of the PC-3 cell but is expressed at higher density on the rear compared with the front of the cell. This channel density gradient combined with a higher density of thapsigarginsensitive Ca2+ stores in the rear of the cell enables the development of an intracellular Ca2+ gradient (low front -high rear) in migrating PC-3 cells that determines migration directionality. Gene silencing of TRPC1 and/or TRPC3, but not TRPC4 or TRPC6, blocks PC-3 cell migration. Permanently suppressing TRPC1 also reduces PC-3 cell proliferation and thereby blocks tumor invasion in vivo. The noninvasive human prostate tumor cell line LNCaP expresses MscCa but the channel undergoes rapid inactivation that prevents Ca2+ gradient development and directional cell migration. Our results indicate that specific forms of mechanical stimuli can switch the inactivating gating mode to the non-inactivating mode seen in PC-3 cells, and this switch is independent of the actin-cytoskeleton. These findings have specific implications regarding the possible role of the increases mechanical forces (e.g., solid stress and interstitial fluid compression) that develop within a growing prostate tumor in promoting its progression to malignancy.
SUBJECT TERMSProstate tumor cell migration, tumor invasion, mechanical forces on tumor progression, Ca2+ channels, transient receptor potential fam...